The House Energy and Commerce Health Subcommittee today opened a two-day hearing on 25 bills designed to address the opioid crisis. Witnesses from the Food and Drug Administration, the Centers for Disease Control and Prevention, and the Substance Abuse and Mental Health Services Administration outlined steps their agencies are taking to address the epidemic. Witnesses from The Kennedy Forum, Community Anti-Drug Coalitions of America, Biotechnology Innovation Organization, Association for Accessible Medicines, and DisposeRx also testified. AHA is weighing in on the bills with the committee. Chairmen of the relevant committees in Congress have said they hope to enact comprehensive legislation by Memorial Day. The subcommittee hearing will continue tomorrow with testimony from additional witnesses. 

Related News Articles

Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and…
Headline
Eligible organizations can apply through May 6 for up to $1 million each for a three-year period to expand opioid and other substance use disorder services in…
Insights and Analysis
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.